Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“Extended Rh Phenotyping in Thalassaemia
Enhancing Transfusion Safety in Chronically Transfused Patients
Patients with thalassaemia often require lifelong regular blood transfusions. Repeated exposure to donor red cell antigens increases the risk of:
Red Cell Alloimmunization
This can lead to:
- Delayed hemolytic transfusion reactions
- Difficulty finding compatible blood
- Reduced survival of transfused RBCs
- Increased transfusion complications
What Is Extended Rh Phenotyping?
Beyond routine ABO and RhD typing, the Rh system includes clinically important antigens:
- C
- c
- E
- e
Extended Rh phenotyping identifies these antigens to provide better antigen-matched transfusion support.
Why Is It Important?
Repeated transfusions may stimulate formation of antibodies such as:
- Anti-E
- Anti-c
- Anti-C
- Anti-e
These antibodies complicate future transfusions and increase transfusion-related morbidity.
Benefits of Extended Rh Matching:
- Reduces alloimmunization risk
- Improves transfusion safety
- Decreases hemolytic reactions
- Improves red cell survival
- Simplifies future compatibility testing
- Enhances long-term patient outcomes
Example:
D Positive | C Negative | c Positive | E Negative | e Positive
A patient lacking C and E antigens may develop:
- Anti-C
- Anti-E antibodies
after exposure to antigen-positive donor blood.
Therefore, antigen-matched transfusion becomes essential.
Why Early Phenotyping Matters:
Best practice recommends performing extended Rh phenotyping:
- Before the first transfusion
or
- Early in the transfusion program
Early testing provides more accurate antigen profiling and helps prevent future complications.
Modern Transfusion Strategies:
Current best practices include:
- Leucoreduced blood components
- Extended Rh matching
- Kell antigen matching
- Antibody screening and monitoring
- Transfusion reaction surveillance
Modern transfusion medicine is evolving toward safer, precision-based patient care.
Final Thought
For thalassaemia patients, transfusion is not temporary — it is lifelong therapy.
Extended Rh phenotyping helps prevent complications before they occur and significantly improves long-term transfusion safety.
Better antigen matching means safer transfusion support.”

Other posts featuring Kalyan Roy on Hemostasis Today.
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care